在Catharanthus roseus提取物中生物活性化合物的药理潜力:全面审查
Keren Celestina Mendonce1,2, Naveen Palani3,2, Suriyaprakash Rajadesingu2
1Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Chengalpattu District, Kattankulathur, Tamil Nadu 603203, India.
Toxicology reports
|April 11, 2025
概括
卡塔兰 (Catharanthus roseus) 提供有价值的生物活性化合物,用于各种药用,包括癌症,糖尿病和感染. 现代技术提高了药物发现和改善治疗策略的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 植物化学 植物化学
- 药物发现 药物发现 药物发现
背景情况:
- 红花 (马达加斯加) 含有具有显著治疗潜力的生物活性化物.
- 像芬布拉斯和芬克里斯这样的关键化合物在癌症化疗中至关重要.
- 这种植物具有抗糖尿病,抗菌,抗炎和神经保护性质.
研究的目的:
- 探索Catharanthus roseus生物活性化合物的多样化药理应用.
- 突出提取,生产和药物输送方面的挑战和进步.
- 强调将传统知识与药物开发的现代技术相结合的潜力.
主要方法:
- 审查现有的关于Catharanthus roseus药理学的文献.
- 讨论先进的技术,如基因工程 (CRISPR-Cas9),机器学习和高性能液体染色学.
- 探索纳米技术用于药物输送系统.
主要成果:
- 卡塔兰 (Catharanthus roseus) 的化合物在癌症治疗,糖尿病管理,传染病治疗和炎症条件中表现出有效性.
- 技术的进步正在解决提取,纯度和生产类化合物的挑战.
- 纳米技术和协同化合物探索显示了提高药物疗效和减少副作用的前景.
结论:
- 卡塔兰 (Catharanthus roseus) 是富含药理活性化合物的丰富来源,具有广泛的治疗意义.
- 技术创新对于优化这些化合物在药物开发中的使用至关重要.
- 未来的研究将传统医学与现代科学相结合,有可能产生革命性的治疗方法.
更多相关视频
08:20Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
6.2K
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
2.1K
相关概念视频
01:24Principles of Drug Action
5.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.6K
01:21Pharmacodynamics: Overview and Principles
903
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
903
01:28Structure-Activity Relationships and Drug Design
460
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
460
01:16Bioequivalence: Overview
887
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
887
01:26Targets for Drug Action: Overview
5.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K
01:29Drug-Receptor Interactions
4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K